Pharmacy Website
Clinic Website

Intelligence » Crohn's Disease » Last Week

Subscribe to get latest posts via email or subscribe to a RSS feed.

Comparison of reference Infliximab and a Biosimilar (CT-P13) in Crohn's Disease (CME/CE)

Wednesday, December 12, 2018 -- (MedPage Today) -- Analysis of real-world data show that CT-P13 is equivalent to infliximab in infliximab-naive patients with CD